Synocrom, manufactured by Croma Pharma, is a leading viscosupplementation solution containing highly purified sodium hyaluronate derived through biofermentation. The product line includes intra-articular injections with varying molecular weights and concentrations (1% and 2%). Its flagship formulations feature cross-linked hyaluronic acid with a molecular weight ranging from 1.6 to 2.0 million Daltons. This ensures optimal viscoelastic properties and extended residency time in the synovial space. The portfolio encompasses Synocrom Mini (1ml), Synocrom Classic (2ml), and Synocrom Forte, providing healthcare practitioners with flexible treatment options for different stages of osteoarthritis and varying joint sizes.